Our nonprofit advocacy partners represent the blood cancer community, providing education and support to patients and caregivers.
Blood Cancer United is on a mission to cure blood cancer and improve the quality of life of all patients and their families.
CLL Society addresses the unmet needs of the chronic lymphocytic leukemia and small lymphocytic lymphoma (CLL / SLL) community through patient education, advocacy, support and research.
HealthTree Foundation is a nonprofit organization dedicated to empowering blood cancer patients and caregivers through personalized education, community support and innovative technology to help them navigate their care journey, while contributing to data that accelerates research, improves outcomes and advances the search for cures.
The International Waldenstrom's Macroglobulinemia Foundation is dedicated to supporting and educating everyone affected by Waldenstrom’s macroglobulinemia to improve patient outcomes, while advancing the search for a cure. Their vision is a world without this rare disease.
The Leukemia Research Foundation funds innovative research, delivers comprehensive education programs and provides meaningful support services for patients, caregivers and families impacted by a leukemia or myelodysplastic syndrome (MDS) diagnosis.
The Lymphoma Research Foundation is the largest nonprofit organization that aims to realize the promise of science to eradicate lymphoma and serve the community touched by this disease.
The Multiple Myeloma Research Foundation is the largest nonprofit in the world solely focused on accelerating a cure for each and every multiple myeloma patient. They drive the development and delivery of next-generation therapies, leverage data to identify optimal and more personalized treatment approaches, and empower myeloma patients and the broader community with information and resources to extend their lives.
The National Comprehensive Cancer Network is a nonprofit alliance of 33 cancer centers that are focused on supporting and educating patients and furthering research to advance cancer care and prevention.
The NCCN publishes guidelines for patients to help learn more about certain diseases, including CLL and MCL. These guidelines are digital booklets that include easy-to-understand information from blood cancer experts. Exploring these materials may help you have more confident discussions with your healthcare team.
NMDPSM is a leader in cell therapy, helping find cures and save lives for patients with blood cancers and disorders.